Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, announced a New Drug Application (NDA) for its LUMISIGHT™ Optical Imaging Agent has been submitted to the U.S. Food and Drug Administration (FDA).
Syft Technologies today announced the release of its next generation Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) technology, Syft Tracer™, at Pittcon 2023. This innovation of real-time, direct injection mass spectrometry (MS) offers platform advancements such as greater sensitivity, unparalleled performance stability, and high reproducibility and repeatability that make the system an industry-scalable solution. Analytical workflows that require fast time to data, high throughput, and continuous operation will benefit significantly from Syft Tracer capabilities.
SurgVision, a high-tech company developing pioneering solutions for fluorescence-guided surgical and interventional oncology, part of the Bracco Group, announces that it has received 510(k) clearance from the U.S. Food and Drug Administration for the EXPLORER AIR® II for use with Pafolacianine (CYTALUX, On Target Laboratories Inc.) during intraoperative fluorescence imaging.
Bruker announces that the United Kingdom is expanding its fundamental research infrastructure with recent orders for two 1.2 GHz Avance™ nuclear magnetic resonance (NMR) spectrometers for the University of Warwick and the University of Birmingham.
Prolira BV, a high-tech company committed to enabling early and effective treatment of patients at risk of developing acute brain failure, announced it has received 510(k) clearance from the Food and Drug Administration (FDA) for the DeltaScan® Brain State Monitor to aid in the diagnosis of acute encephalopathy in hospitalized patients over 60 years of age.
Picarro Inc., a leading provider of chemical metrology systems for advanced semiconductor fabs, announced the SLiM 100 Lithography Process Tool Monitoring System. The new 1-ppb class chemical metrology solution detects volatile organic compounds (VOCs) in the lithography process in real time, enabling semiconductor manufacturers to quickly take steps to prevent excursions and detect non-visual defects, thereby improving yield.
Visby Medical™ announced that it has received 510(k) clearance and was granted a CLIA waiver from the U.S. Food and Drug Administration for its second generation point of care (POC) test. The Visby Medical Sexual Health test is a fast, polymerase chain reaction (PCR) diagnostic test for the detection of sexually transmitted infections (STIs) caused by Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in women.
DISC Surgery Center at Newport Beach ("DISC") has deepened its partnership with Blue Shield of California ("Blue Shield") to both advance and increase access to leading-edge spine care in the outpatient setting.Announcement is the result of a thoughtful and swift negotiation. DISC, through parent company TriasMD, was one of the first surgery centers in California to work directly with Blue Shield in 2023 to establish a new and expansive contract.
PENTAX Medical Americas, a division of HOYA Group, is excited to announce that it has obtained CE marks, clearing it for commercialization in the European Union for two of its latest innovations: the PENTAX Medical INSPIRA™ premium video processor and the i20c video endoscope series.
Children's Minnesota is thrilled to announce it is the first health system in North America to open a pediatric hybrid intraoperative magnetic resonance imaging (iMRI) suite equipped with both moving-scanner and moving-patient MRI technology in the same surgical space.